Pharmaceutical stocks came under renewed selling pressure on Thursday as one of the City’s leading analysts forecast drug companies would continue to underperform.

The UK pharmaceutical sector fell 5.2 per cent last year - underperforming the FTSE All Share by 16.2 per cent - amid worries over drug pipelines and the threat of political intervention in the US.